Table 3. Examples of how dimensions of technology-related prescribing errors can be used to prioritise CPOE optimisation goals.
Optimisation goal | Relevant TRE dimension to begin review | Explanation |
Reduce dose errors | Manifestation of error (data subset: all dose errors) | Examine dose errors to ascertain their underlying mechanisms to identify areas for CPOE improvement. Dose errors can be further stratified by those with potential or actual harm to patients. |
Reduce errors with a high risk to patient safety | Manifestation of error (data subset: errors rated as having a high potential for harm AND errors with high-risk medications) | Examine errors with higher potential harm rating and errors with high-risk medications to identify their underlying mechanisms. These can be further stratified by their clinical error category (eg, duplicate therapy error). |
Optimise CPOE drop-down menus | Underlying mechanisms of errors (data subset: selection errors) | Examine all selection errors and their manifestations (ie, clinical error types) to identify where they are occurring at a higher frequency, signalling need for drop-down menu modification. |
CPOEcomputerised provider order entryTREtechnology-related error